ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,769.96
0.38%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.764
-0.07%
Brent Oil
82.015
0.04%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. PAVmed Inc (PAVM)

  7. PAVmed Inc (PAVM) ニュース

PAVM

PAVmed (PAVM)

PAVmed Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PAVM
日付受信時刻ニュースソース見出しコード企業名
2024/05/1409 : 43PR Newswire (US)PAVmed Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
2024/05/1321 : 00PR Newswire (US)Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial ResultsNASDAQ:PAVMPAVmed Inc
2024/05/0920 : 49PR Newswire (US)Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA RecallNASDAQ:PAVMPAVmed Inc
2024/05/0720 : 39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:PAVMPAVmed Inc
2024/05/0321 : 35PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024NASDAQ:PAVMPAVmed Inc
2024/05/0221 : 35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:PAVMPAVmed Inc
2024/05/0220 : 49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:PAVMPAVmed Inc
2024/04/3020 : 35PR Newswire (US)PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research InstituteNASDAQ:PAVMPAVmed Inc
2024/04/2921 : 47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:PAVMPAVmed Inc
2024/04/0821 : 30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PAVMPAVmed Inc
2024/03/2708 : 32PR Newswire (US)PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PAVMPAVmed Inc
2024/03/2122 : 30PR Newswire (US)Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:PAVMPAVmed Inc
2024/03/2121 : 30PR Newswire (US)PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpXNASDAQ:PAVMPAVmed Inc
2024/03/2021 : 30PR Newswire (US)Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceNASDAQ:PAVMPAVmed Inc
2024/03/1321 : 30PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024NASDAQ:PAVMPAVmed Inc
2024/03/1221 : 30PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024NASDAQ:PAVMPAVmed Inc
2024/03/0906 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMPAVmed Inc
2024/02/2406 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PAVMPAVmed Inc
2024/02/2406 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PAVMPAVmed Inc
2024/02/2406 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PAVMPAVmed Inc
2024/02/2406 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PAVMPAVmed Inc
2024/02/2106 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PAVMPAVmed Inc
2024/02/2106 : 45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PAVMPAVmed Inc
2024/02/1707 : 00PR Newswire (US)Lucid Diagnostics Provides Update Regarding World Trade Center Health ProgramNASDAQ:PAVMPAVmed Inc
2024/02/1521 : 45PR Newswire (US)Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyNASDAQ:PAVMPAVmed Inc
2024/02/1505 : 38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PAVMPAVmed Inc
2024/02/1006 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PAVMPAVmed Inc
2024/02/0821 : 45PR Newswire (US)Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsNASDAQ:PAVMPAVmed Inc
2024/02/0707 : 17Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PAVMPAVmed Inc
2024/02/0707 : 16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PAVMPAVmed Inc
 Showing the most relevant articles for your search:NASDAQ:PAVM

最近閲覧した銘柄

BITMOT
932832
Keelt Group Tf 6% Gn27 A...
NASDAQ
AAWOQXX
Jpmorgan Chase Financial...
NASDAQ
FIAEX
Fidelity Sustainable Cor...
TSXV
FCV
Focus Ventures Ltd.
BOV
BBASS450
BBASS450 Ex:21,97
LATK
OAPETH
Open Alexa Protocol
DBI
AMWA
DAX ESG TARGET NR
BIT
UB4QBB
Unicredit Bank
AMEX
UVXY
ProShares Ultra VIX Shor...
BIT
UIJ778
Unicredit Bank
EU
EMWE
BNP Paribas Easy MSCI Wo...
AQSE
XNIF.GB
Xtrackers Nifty 50 Swap ...
TSX
DXET
Dynamic Active Energy Ev...
BIT
FLV049
Vontobel
NASDAQ
FGCFKX
Strategic Dividend Selec...
AMEX
WCAT
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有